Rankings
▼
Calendar
ANIK FY 2014 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$207M
FY 2014 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$106M
+40.6% YoY
Gross Profit
$85M
80.2% margin
Operating Income
$61M
58.2% margin
Net Income
$38M
36.3% margin
EPS (Diluted)
$2.51
Cash Flow
Operating Cash Flow
$40M
Free Cash Flow
$38M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$194M
Total Liabilities
$16M
Stockholders' Equity
$178M
Cash & Equivalents
$100M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$106M
$75M
+40.6%
Gross Profit
$85M
$52M
+61.8%
Operating Income
$61M
$33M
+88.4%
Net Income
$38M
$21M
+86.2%
← FY 2013
All Quarters
FY 2015 →